Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05326815 · ClinicalTrials.gov registry record
A Comparison of Serum and Urine N-telopeptide Marker
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 54
- Enrollment target
NCT05326815 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 54 participants.
The verdict
NCT05326815 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
This is a prospective specimen collection cohort study to evaluate the correlation between serum and urine values of the bone marker of interest, and their association with baseline DEXA scan measures and fracture risk within 6 months. Study samples will be obtained longitudinally. One collection of both serum and urine collection will be obtained. The urine will be collected as second void of day and at the same time the blood collection is drawn. Study will continue for a period or 1 year, with plan to enroll around 40 subjects.
Interventions
- DIAGNOSTIC_TEST N-Telopeptide, Bone Marker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2022-06-23 |
| Est. Completion | 2023-10-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05326815
The ClinicalTrials.gov registry entry for NCT05326815 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which N-Telopeptide, Bone Marker is the first listed.
NCT05326815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05326815 about?
NCT05326815 is a clinical study titled "A Comparison of Serum and Urine N-telopeptide Marker". This is a prospective specimen collection cohort study to evaluate the correlation between serum and urine values of the bone marker of interest, and their association with baseline DEXA scan measures and fracture risk within 6 months. Study samples will be obtained longitudinally. One collection o...
What is the current status of trial NCT05326815?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2022-06-23. Estimated completion is 2023-10-27.
What interventions are being tested in trial NCT05326815?
The interventions under investigation include: N-Telopeptide, Bone Marker (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05326815?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.